TABLE 2

Biodistribution of [99mTc]Demobesin 1 in Human PC3 Xenograft–Bearing SCID Mice at 1, 4, and 24 Hours After Injection

[99mTc]Demobesin 1
Organ1 h4 h24 h
Blood1.36 ± 0.090.24 ± 0.060.07 ± 0.01
Liver9.62 ± 0.976.62 ± 0.662.61 ± 0.16
Heart0.76 ± 0.080.19 ± 0.030.14 ± 0.03
Kidneys8.08 ± 0.654.33 ± 0.441.02 ± 0.18
Stomach2.10 ± 0.302.12 ± 0.481.37 ± 0.98
Intestines10.27 ± 0.5510.36 ± 0.461.35 ± 0.51
Blocked intestines*ND10.72 ± 0.85ND
Spleen1.66 ± 0.251.68 ± 0.940.90 ± 0.17
Muscle0.24 ± 0.020.06 ± 0.010.04 ± 0.01
Lungs1.37 ± 0.120.38 ± 0.050.15 ± 0.02
Pancreas104.39 ± 3.5949.82 ± 6.691.29 ± 0.46
Blocked pancreas*ND6.48 ± 0.20§ND
PC3 tumor24.61 ± 1.9822.66 ± 2.205.38 ± 0.72
Blocked tumor*ND5.19 ± 1.35§ND
Tumor/blood18.1094.4276.86
Tumor/muscle102.54377.67134.50
Tumor/liver2.603.422.06
Tumor/kidney3.005.235.27
  • * In vivo blockade was achieved by coinjection of 100 μg [Tyr4]bombesin.

  • Statistical analysis was performed using the Student t test with P values indicating extremely significant difference (§P < 0.001) vs. unblocked. P > 0.5 (not significant).

  • ND = not determined.

  • Data are expressed as ID%/g (percentage injected dose per gram) and are presented as mean ± SD (n = 4).